Amino acids of the α 1B‐adrenergic receptor involved in agonist binding: differences in docking catecholamines to receptor subtypes

No abstract is available for this paper.

• Publication year

  1996

• Venue

  FEBS Letters

• Publication date

  1996-12-09

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0014-5793(96)01286-0PMID 8980109
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Constitutively active mutants of the alpha 1B‐adrenergic receptor: role of highly conserved polar amino acids in receptor activation.

  1996cited by this paper
• The Unique Nature of the Serine Interactions for -Adrenergic Receptor Agonist Binding and Activation (*)

  1996cited by this paper
• Identification of critical determinants of alpha 1-adrenergic receptor subtype selective agonist binding.

  1995cited by this paper
• Identification of Critical Determinants of α1-Adrenergic Receptor Subtype Selective Agonist Binding (*)

  1995cited by this paper
• Truncation of the receptor carboxyl terminus impairs agonist-dependent phosphorylation and desensitization of the alpha 1B-adrenergic receptor.

  1994cited by this paper
• In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors.

  1992cited by this paper
• Contributions of Conserved Serine Residues to the Interactions of Ligands with Dopamine D2 Receptors

  1992cited by this paper
• Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation.

  1992cited by this paper
• Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5.

  1991cited by this paper
• Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists.

  1991cited by this paper
• Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor.

  1989cited by this paper
• Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor.

  1988cited by this paper
• Identification of residues required for ligand binding to the beta-adrenergic receptor.

  1987cited by this paper
• CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

  1983cited by this paper
• Interaction of calmodulin with myosin light chain kinase and cAMP-dependent protein kinase in bovine brain.

  1981cited by this paper

• Evaluating the conformational space of the active site of D2 dopamine receptor. Scope and limitations of the standard docking methods

  2022cites this paper
• Critical APJ receptor residues in extracellular domains that influence effector selectivity

  2021cites this paper
• Motions around conserved helical weak spots facilitate GPCR activation

  2021cites this paper
• Determinants of Ligand Subtype-Selectivity at α1A-Adrenoceptor Revealed Using Saturation Transfer Difference (STD) NMR.

  2018cites this paper
• Aminergic GPCR-Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data.

  2018cites this paper
• Template selection and refinement considerations for modelling aminergic GPCR-ligand complexes.

  2017cites this paper
• Conserved Mechanism of Conformational Stability and Dynamics in G-Protein-Coupled Receptors.

  2016cites this paper
• Dopamine D1 receptor-agonist interactions: A mutagenesis and homology modeling study.

  2015cites this paper
• Differences in allosteric communication pipelines in the inactive and active states of a GPCR.

  2014cites this paper
• An aspartate in the second extracellular loop of the α(1B) adrenoceptor regulates agonist binding.

  2014cites this paper
• Molecular exploration of the α1A‐adrenoceptor orthosteric site: Binding site definition for epinephrine, HEAT and prazosin

  2014cites this paper
• High affinity ligands and potent antagonists for the α1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.

  2014cites this paper
• Homology Models of Melatonin Receptors: Challenges and Recent Advances

  2013cites this paper
• 5-HT1A receptor pharmacophores to screen for off-target activity of α1-adrenoceptor antagonists

  2013cites this paper
• Orthosteric Binding of ρ-Da1a, a Natural Peptide of Snake Venom Interacting Selectively with the α1A-Adrenoceptor

  2013cites this paper
• Study of the selectivity of α1-adrenergic antagonists by molecular modeling of α1a-, α1b-, and α1d-adrenergic receptor subtypes and docking simulations

  2013cites this paper
• MT1‐Selective Melatonin Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Dynamics Investigation of N‐{[(3‐O‐Substituted)anilino]alkyl}amides

  2012cites this paper
• Investigation of D1 Receptor–Agonist Interactions and D1/D2 Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling

  2012cites this paper
• Update 1 of: computational modeling approaches to structure-function analysis of G protein-coupled receptors.

  2011cites this paper
• Modeling the interactions between alpha(1)-adrenergic receptors and their antagonists.

  2010cites this paper
• Constitutive activity and inverse agonism at the α(₁a) and α(₁b) adrenergic receptor subtypes.

  2010cites this paper
• Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerization-defective α1b-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers

  2008cites this paper
• Amino Acids of the Human α1d-Adrenergic Receptor Involved in Antagonist Binding

  2008cites this paper
• Computational Modeling of Selective Pharmacophores at the α1‐Adrenergic Receptors

  2008cites this paper
• Amino acids of the human alpha1d-adrenergic receptor involved in antagonist binding.

  2008cites this paper
• Mutational analysis of the alpha 1a-adrenergic receptor binding pocket of antagonists by radioligand binding assay.

  2008cites this paper
• Recent advances in the discovery of alpha1-adrenoceptor agonists.

  2007cites this paper
• Asp125 and Thr130 in transmembrane domain 3 are major sites of alpha1b-adrenergic receptor antagonist binding.

  2007cites this paper
• The angiotensin II AT1 receptor structure-activity correlations in the light of rhodopsin structure.

  2007cites this paper
• Systematic analysis of the entire second extracellular loop of the V(1a) vasopressin receptor: key residues, conserved throughout a G-protein-coupled receptor family, identified.

  2007cites this paper
• MCH-R1 antagonists based on an arginine scaffold: SAR studies on the amino-terminus.

  2007cites this paper
• Constitutive activity and inverse agonism at the alpha1adrenoceptors.

  2007cites this paper
• Large-scale molecular dynamics of a G protein-coupled receptor, the human 5-HT4 serotonin receptor, in a lipid bilayer

  2007cites this paper
• The in silico insights of alpha-adrenergic receptors over the last decade: methodological approaches and structural features of the 3D models.

  2007cites this paper
• Computational study of antagonist/alpha1A adrenoceptor complexes--observations of conformational variations on the formation of ligand/receptor complexes.

  2006cites this paper
• A Genetic-Function-Approximation-Based QSAR Model for the Affinity of Arylpiperazines toward alpha1 Adrenoceptors

  2006cites this paper
• Structural Determinants of Pharmacological Specificity Between D1 and D2 Dopamine Receptors

  2006influential citation
• Ligand Binding, Activation, and Agonist Trafficking

  2006cites this paper
• Structure and function of dopamine receptors : ligand binding and arrestin binding

  2006cites this paper
• Comparative molecular dynamics simulations of uncomplexed, 'agonist-bound' and 'antagonist-bound' alpha1A adrenoceptor models.

  2005cites this paper
• Computational modeling approaches to structure-function analysis of G protein-coupled receptors.

  2005cites this paper
• Modelling the Interaction of Catecholamines with the α1A Adrenoceptor Towards a Ligand-induced Receptor Structure

  2005cites this paper
• Structural determinants involved in the activation and regulation of G protein-coupled receptors: lessons from the alpha1-adrenegic receptor subtypes.

  2004cites this paper
• Structure-activity relationship of coordinated catecholamine in the [Ru(III)(NH3)4(catecholamine)]+ complex.

  2004cites this paper
• Structural features of the inactive and active states of the melanin‐concentrating hormone receptors: Insights from molecular simulations

  2004influential citation
• Structural determinants involved in the activation and regulation of G protein‐coupled receptors: lessons from the alpha1‐adrenegic receptor subtypes

  2004cites this paper
• Site-directed mutagenesis studies on the Drosophila octopamine/tyramine receptor.

  2003cites this paper
• Agonist-specific coupling of a cloned human α1A-adrenoceptor to different second messenger pathways

  2003cites this paper
• Structural Analysis of the Mammalian D2, D3 and D4 Dopamine Receptors

  2003cites this paper
• Molecular Dynamics Simulations of the Ligand-Induced Chemical Information Transfer in the 5-HT1A Receptor

  2003cites this paper
• Molecular dynamics simulations of the ligand-induced chemical information transfer in the 5-HT(1A) receptor.

  2003cites this paper
• Design, synthesis and pharmacological evaluation of 5-hydroxytryptamine(1a) receptor ligands to explore the three-dimensional structure of the receptor.

  2002cites this paper
• THE α1b-ADRENERGIC RECEPTOR SUBTYPE: MOLECULAR PROPERTIES AND PHYSIOLOGICAL IMPLICATIONS

  2002cites this paper
• Mechanisms of ligand binding and efficacy at the human D2(short) dopamine receptor

  2002cites this paper
• The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop.

  2002cites this paper
• THE BINDING SITE OF AMINERGIC GP ROTEIN-COUPLED RECEPTORS:

  2002cites this paper
• Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.

  2002cites this paper
• Theoretical evidence of a salt bridge disruption as the initiating process for the α1d‐adrenergic receptor activation: A molecular dynamics and docking study

  2001cites this paper
• Ligand design for alpha(1) adrenoceptors.

  2001cites this paper
• Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.

  2001cites this paper
• Ligand Recognition of Serine—Cysteine Amino Acid Exchanges in Transmembrane Domain 5 of α2‐Adrenergic Receptors by UK 14,304

  2000cites this paper
• Effect of Multiple Serine/Alanine Mutations in the Transmembrane Spanning Region V of the D2 Dopamine Receptor on Ligand Binding

  2000cites this paper
• Catechol-Binding Serines of β2-Adrenergic Receptors Control the Equilibrium between Active and Inactive Receptor States

  2000cites this paper
• Exploration of the ligand binding site of the human 5‐HT4 receptor by site‐directed mutagenesis and molecular modeling

  2000cites this paper
• The alpha 1a and alpha 1b-adrenergic receptor subtypes: molecular mechanisms of receptor activation and of drug action.

  2000cites this paper
• Scanning mutagenesis identifies amino acid side chains in transmembrane domain 5 of the M(1) muscarinic receptor that participate in binding the acetyl methyl group of acetylcholine.

  2000cites this paper
• The α1a and α1b-adrenergic receptor subtypes: molecular mechanisms of receptor activation and of drug action

  2000cites this paper
• The Forgotten Serine

  2000cites this paper
• Receptors coupling to G proteins: Is there a signal behind the sequence?

  2000cites this paper
• Theoretical study on mutation-induced activation of the luteinizing hormone receptor.

  2000cites this paper
• Inverse agonism and neutral antagonism at alpha(1a)- and alpha(1b)-adrenergic receptor subtypes.

  1999cites this paper
• Theoretical study on receptor-G protein recognition: new insights into the mechanism of the α1b-adrenergic receptor activation

  1999cites this paper
• Ser203 as well as Ser204 and Ser207 in fifth transmembrane domain of the human β2‐adrenoceptor contributes to agonist binding and receptor activation

  1999cites this paper
• Structure-function relationships of the alpha1b-adrenergic receptor.

  1999cites this paper
• Molecular modelling, design and synthesis of α₁-adrenergic receptor antagonists

  1999cites this paper
• Structure-Function Relationships of the α1b-Adrenergic Receptor

  1999cites this paper
• Inverse Agonism and Neutral Antagonism at α1a- and α1b-Adrenergic Receptor Subtypes

  1999cites this paper
• Chloroethylclonidine binds irreversibly to exposed cysteines in the fifth membrane-spanning domain of the human alpha2A-adrenergic receptor.

  1998cites this paper
• Isoxazolo-[3,4-d]-pyridazin-7-(6H)-ones and their corresponding 4,5-disubstituted-3-(2H)-pyridazinone analogues as new substrates for alpha1-adrenoceptor selective antagonists: synthesis, modeling, and binding studies.

  1998cites this paper
• Computer modeling of size and shape descriptors of alpha 1-adrenergic receptor antagonists and quantitative structure-affinity/selectivity relationships.

  1998cites this paper
• Molecular mechanisms involved in the activation and regulation of the alpha 1-adrenergic receptor subtypes.

  1998cites this paper
• G protein coupled receptors as modules of interacting proteins: a family meeting.

  1997cites this paper